6th Annual International Breast Cancer Conference - Hall B - 19 Nov 2022
Welcome & Introduction
Biomarker - based Targeted therapy for Colorectal Cancer
No Name
Novel Targeted agents in Gastric Cancer
PancreaticCancer Newertratement Options
Novel Agents and Targets in HCC
Update on Management of Advanced Biliary Tract cancer
Management of Metastic Hormon Prostate Cancer
Selection of RX for RCC-Adjuvant &1st Line Rx in Metastatic disease
2nd Line options in Renal Cell Cancer
First-Line Immunotherapy in the management of RCC
Panel Discussion - Metastatic RCC
Current Treatment Landscape in first-line Urothelial Cancer
Overall survival at its core The New ABC Avelumab in Bladder Cancer
Panel Discussion- Management of Advance Bladder Cancer
Advances in Novel Formulation of Taxanes
Panel discussion - Management of Prostate cancer
Closing Remarks